Chemist Warehouse will take control of Sigma Healthcare in a reverse listing that will bring the pharmaceutical retailer, which is controlled by the billionaire Gance and Verrocchi families, to the ASX for the first time.
The key components have been agreed upon and are expected to be outlined as soon as Friday. A $350 million capital raising was being handled by Goldman Sachs, sources told The Australian Financial Review.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
